News Summary: Alzheimer drug may slow brain plaque

Published



MORE DISAPPOINTMENT: Two major studies of an experimental Alzheimer’s drug show it doesn’t stop mental decline, the latest setback in finding a treatment for the mind-robbing disease.

HOPEFUL SIGN: There was a hint that the drug bapineuzumab, made by Pfizer Inc. and Johnson & Johnson, might help if given sooner, before the disease has caused too much damage and memory loss.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.